Login / Signup

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.

Pauline Byakika-KibwikaRonald SsenyongaMohammed LamordeDaniel BlessbornJoel Tarning
Published in: BMC infectious diseases (2019)
The study was registered with the Pan African Clinical Trial Registry (PACTR201110000321348). Registered 7th October 2011.
Keyphrases
  • plasmodium falciparum
  • clinical trial
  • young adults
  • drug administration
  • high dose
  • study protocol
  • early onset
  • phase ii
  • open label
  • randomized controlled trial
  • newly diagnosed
  • phase iii